(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|
Turnover | ---- | -98.80%617K | --617K | --51.63M | ---- | ---- | ---- | ---- | ---- |
Operating income | -98.80%617K | 617K | 51.63M | ||||||
Operating expenses | |||||||||
Gross profit | |||||||||
Selling expenses | ---- | 94.72%-1.42M | 91.02%-1.38M | ---26.86M | ---15.38M | ---- | ---- | ---- | ---- |
Administrative expenses | 23.53%-78.63M | -16.53%-196.5M | -7.71%-102.82M | 19.09%-168.63M | -40.41%-95.47M | -101.56%-208.4M | ---67.99M | -63.26%-103.4M | ---63.33M |
Research and development expenses | 37.59%-126.17M | 8.61%-402.71M | 21.78%-202.18M | 10.91%-440.63M | -64.00%-258.48M | 43.52%-494.62M | ---157.61M | -945.29%-875.8M | ---83.79M |
Revaluation surplus | ---- | ---- | ---- | ---- | ---- | -927.15%-3.6B | ---2.75B | 12.75%-350.37M | ---401.58M |
-Changes in the fair value of other assets | ---- | ---- | ---- | ---- | ---- | -927.15%-3.6B | ---2.75B | 12.75%-350.37M | ---401.58M |
Impairment and provision | ---32.96M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Other impairment is provision | ---32.96M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Special items of operating profit | -140.75%-44.5M | 335.43%416.13M | 2,504.08%109.19M | -14.64%95.57M | -82.88%4.19M | 134.61%111.96M | --24.49M | 65.82%47.72M | --28.78M |
Operating profit | -43.59%-282.25M | 62.39%-183.88M | 46.16%-196.57M | 88.33%-488.93M | 87.63%-365.13M | -226.87%-4.19B | -2.95B | -146.55%-1.28B | -519.92M |
Financing cost | -289.37%-989K | 41.95%-494K | 47.08%-254K | 27.57%-851K | 46.25%-480K | 29.56%-1.18M | ---893K | -49.87%-1.67M | ---1.11M |
Earning before tax | -43.90%-283.24M | 62.36%-184.37M | 46.17%-196.83M | 88.31%-489.78M | 87.62%-365.61M | -226.53%-4.19B | -2.95B | -146.34%-1.28B | -521.03M |
After-tax profit from continuing operations | -43.90%-283.24M | 62.36%-184.37M | 46.17%-196.83M | 88.31%-489.78M | 87.62%-365.61M | -226.53%-4.19B | -2.95B | -146.34%-1.28B | -521.03M |
Earning after tax | -43.90%-283.24M | 62.36%-184.37M | 46.17%-196.83M | 88.31%-489.78M | 87.62%-365.61M | -226.53%-4.19B | -2.95B | -146.34%-1.28B | -521.03M |
Minority profit | 60.88%-2.7M | -74.46%-9.54M | 61.67%-6.91M | 79.92%-5.47M | -4,384.33%-18.03M | 71.00%-27.24M | ---402K | ---93.91M | ---- |
Profit attributable to shareholders | -47.71%-280.54M | 63.90%-174.83M | 45.36%-189.92M | 88.37%-484.31M | 88.23%-347.59M | -250.02%-4.16B | -2.95B | -128.32%-1.19B | -521.03M |
Basic earnings per share | -46.15%-0.38 | 64.18%-0.24 | 45.83%-0.26 | 92.93%-0.67 | 96.77%-0.48 | -52.41%-9.48 | -14.86 | -113.01%-6.22 | -2.92 |
Diluted earnings per share | -46.15%-0.38 | 64.18%-0.24 | 45.83%-0.26 | 92.93%-0.67 | 96.77%-0.48 | -52.41%-9.48 | -14.86 | -113.01%-6.22 | -2.92 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data